Related Articles
Comparison of adjuvant ED and EC-D regimens in operable breast invasive ductal carcinoma
Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: randomized trial, can it improve survival of patients with good prognostic factors?
A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting
RANDOMIZED TRIAL COMPARING ADRIAMYCIN VINCRISTINE (AV) CYCLOPHOSPHAMIDE METHOTREXATE 5-FLUOROURACIL PREDNISONE (CMFP) HYBRID VERSUS AV-CMFP MONTHLY ALTERNATED IN METASTATIC BREAST-CANCER
Multicyclic dose-intensive chemotherapy with circulating progenitor cell support for high-risk primary breast cancer.